More specifically, high ASAP1 expression was revealed to be related to worse MRFS of patients with TNBC (n = 257), but not ER+ BC (n = 2519) (Fig. 4e), as assessed in the cohorts of BC patients [16]. Here, ASAP1 is linked to breast cancer.